Gilead initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Published first on TheFly – the ...
Zacks.com on MSN10d
Gilead Science to Report Q3 Earnings: What's in the Cards?
Inc. price-consensus-eps-surprise-chart | Gilead Sciences, Inc. Quote Our proven model predicts an earnings beat for Gilead ...
Morningstar8d
Gilead Sciences Inc GILD
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
moneycontrol.com6d
Gilead Sciences
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Wolfe Research starts Gilead at Outperform on ‘multiple shots on goal’
Wolfe Research initiated coverage of Gilead (GILD) with an Outperform rating and $110 price target Gilead’s bread and butter has been ...
MarketWatch8d
Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidance
Gilead Sciences Inc.’s stock rose 2.7% in after-hours trading Wednesday, after the biotech blew past third-quarter earnings estimates and raised its guidance, boosted by demand for its HIV and ...